ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Rep. Regula To Lead House Labor, HHS; Specter Likely Senate Labor, HHS Chairman.

January 12, 2001

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

ONS To Fund 21 Grants In ’94 Deadline Dec. 1

June 11, 1993